Telesis Bio Inc 's ROA from the third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Telesis Bio Inc 's ROA in the third quarter of 2024?
Telesis Bio Inc recorded a cumulative net loss of $-46 million during 12 months ending in the third quarter of 2024, resulting in a negative return on assets (ROA) of -86.5%.

However, within the Healthcare sector 785 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2024 from 4489 to 4549.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Total Assets Change	-76.45 %	-53.96 %	-28.97 %	-15.29 %	-87.45 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-46	-50	-45	-48	-38
Return On Assets (TTM)	-86.5 %	-68.11 %	-51.31 %	-50.43 %	-39.03 %
TBIO's Total Ranking	# 4549	# 4489	# 4356	# 5020	# 4290
Total Assets (TTM) in million	25	53	63	70	105
Seq. Total Assets Change	-53.08 %	-16.74 %	-9.31 %	-33.51 %	-8.29 %
Seq. Net Income Change	-	-	-	-	-

TBIO's 5 Years Annual ROA >> Back to TBIO Management Effectiveness >> Compare TBIO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 27
Sector	# 786
Overall	# 4464

Return On Assets Statistics
High	Average	Low
4.97 %	-30.27 %	-86.27 %
(Mar 31 2023)		(Sep 30 2024)

Financial Statements
Telesis Bio Inc 's Assets	$ 25 million	TBIO's Balance sheet
Telesis Bio Inc 's Income	$ -7 million	Quarterly TBIO's Income Statement
TBIO's Income by Division		See TBIO's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2017) FY 2018
Y / Y Total Assets Change	-13.46 %	-89.72 %	141.35 %	37.13 %	-
Total Assets in million	70	81	792	328	239
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-48	-48	-54	-113	-66
Annual Return On Assets	-67.78 %	-59.57 %	-6.79 %	-34.54 %	-27.77 %

TBIO's 5 Years Annual ROA >> Back to TBIO Management Effectiveness >> Compare TBIO ROA to its Competitors

More Return On Assets Ratios
TBIO's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TBIO's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TBIO's Competitors
Subscribers only: Roa for Telesis Bio Inc 's Suppliers
Subscribers only: Return On Assets for TBIO's Customers

You may also want to know
TBIO's Roi	TBIO's Inventory Turnover Ratio	TBIO's Growth Rates	TBIO's Dividend Comparisons
	TBIO's Profitability Ratios	TBIO's Asset Turnover Ratio	TBIO's Dividend Growth
TBIO's Roe	TBIO's Valuation Ratios	TBIO's Financial Strength Ratios	TBIO's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:40:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.